Ginsenoside Rg3의 함량증가를 위한 변환 기술

키워드

참고문헌 (137)

1. Akao T, "Intestinal bacterial hydrolysis is required for the appearance of compound K in rat plasma after oral administration of ginsenoside Rb1 from Panax ginseng", Journal of Pharmacology, 50, pp.1155~1160 (1998)
2. Andreea Neculai M, "Partial purification and characterization of three ginsenosidemetabolizing beta-glucosidases from Pythium irregulare", Phytochemistry, 70, pp.1948~1957 (2009)
3. Anufriev VP, "Synthesis of ginsenoside Rg3, a minor constituent of Ginseng radix", Carbohydrate Research, 304, pp.179~182 (1997)
4. Attele AS, "Ginseng pharmacology : Multiple constituents and multiple actions", Biochemical Pharmacology, 58, pp.1685~1693 (1999)
5. Bae EA, "Constitutive betaglucosidases hydrolyzing ginsenoside Rb1 and Rb2 from human intestinal bacteria", Biological and Pharmaceutical Bulletin, 23, pp.1481~1485 (2000)
6. ae EA, "Metabolism of ginsenoside Rc by human intestinal bacteria and its related antiallergic activity", Biologicaland Pharmaceutical Bulletin, 25, pp.743~747 (2002)
7. Bae EA, "Metabolism of 20(S)-and 20(R)-ginsenoside Rg3 by human intestinal bacteria and its relation to in vitro biological activities", Biological and Pharmaceutical Bulletin, 25, pp.58~63 (2002)
8. Eun-Ah Bae, "Transformation of Ginseng Saponins to Ginsenoside Rh2 by Acids and Human Intestinal Bacteria and Biological Activities of Their Transformants", Archives of Pharmacal Research, 27(1), pp.61~67 (2004), 대한약학회
9. Young-Ju Ban, "Optimization of the Manufacturing Process for Black Ginseng", Journal of the Korean Society for Applied Biological Chemistry, 53(1), pp.71~77 (2010), 한국응용생명화학회
10. Burdock GA, "Generally recognized as safe (GRAS): history and description", Toxicology Letters, 150, pp.3~18 (2004)
11. Chang KH, "Optimization of the enzymatic production of 20(S)- ginsenoside Rg3 from white ginseng extract using response surface methodology", New Biotechnology, 26, pp.181~186 (2009)
12. Chen G, "Microbial transformation of 20(S)-protopanaxatriol-type saponins by Absidia coerulea", Journal of Natural Prouducts, 70, pp.1203~1206 (2007)
13. Chen GT, "Microbial transformation of ginsenoside Rb1 by Acremonium strictum", Applied Microbiology and Biotechnology, 77, pp.1345~1350 (2008)
14. Chen J, "Research on the antitumor effect of ginsenoside Rg3 in B16 melanoma cells", Melanoma Research, 18, pp.322~329 (2008)
15. Chen JY, "Effect of sugar positionsin ginsenosides and their inhibitory potency on Na+", K+-ATPase activity, 2009, pp.30, 61~69
16. Cheng LQ, "Conversion of major ginsenoside Rb1 to ginsenoside F2 by Caulobacter leidyia", Biotechnology Letters, 28, pp.1121~1127 (2006)
17. Cheng LQ, "Conversion of major ginsenoside Rb1 to 20(S)-ginsenoside Rg3 by Microbacterium sp. GS514", Phytochemistry, 69, pp.218~224 (2008)
18. CHENG, LE-QIN, "Microbial Conversion of Ginsenoside Rb1 to Minor Ginsenoside F2 and Gypenoside XVII by Intrasporangium sp. GS603 Isolated from Soil", Journal of Microbiology and Biotechnology, 17(12), pp.1937~1943 (2007), 한국미생물·생명공학회
19. Christensen LP., "Ginsenosides chemistry, biosynthesis, analysis, and potential health effects", Advances in Food and Nutrition Research, 55, pp.1~99 (2009)
20. De Smet PA., "Herbal remedies", The New England Journal of Medicine, 347, pp.2046~2056 (2002)
21. Dong A, "Microbial transformation of ginsenoside Rb1 by Rhizopus stolonifer and Curvularia lunata", Biotechnology Letters, 25, pp.339~344 (2003)
22. Dong H, "The in vitro structure-related anticancer activity of ginsenosides and their derivatives", Molecules and Cells, 16, pp.10619~10630 (2011)
23. Fuzzati N., "Analysis methods of ginsenosides", Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences, 812, pp.119833~ (2004)
24. Ha YW, "Validated quantification for selective cellular uptake of ginsenosides on MCF-7 human breast cancer cells by liquid chromatography-mass spectrometry", Analytical and Bioanalytical Chemistry, 396, pp.3017~3025 (2010)
25. Haki GD, "Developments in industrially important thermostable enzymes", Bioresource Technology, 89, pp.17~34 (2003)
26. Han Y, "Transformation of bioactive compounds by Fusarium sacchari fungus isolated from the soil-cultivated ginseng", Journal of Agricultural and Food Chemistry, 55, pp.9373~9379 (2007)
27. Hasegawa H, "Main ginseng saponin metabolites formed by intestinal bacteria", Planta Medica, 62, pp.453~457 (1996)
28. Hasegawa H, "Efficacy of orally administered ginsenoside Rb1 in dependence on intestinal bacterial hydrolyzing potential and significance of treatment with an active bacterial metabolite", Planta Medica, 649, pp.696~700 (1998)
29. 현진원, "Inhibition of Telomerase Activity in U937 Human Monocytic Leukemia Cells by Compound K, a Ginseng Saponin Metabolite", Biotechnology and Bioprocess Engineering, 11(1), pp.7~12 (2006), 한국생물공학회
30. Kang KS, "Study on the hydroxyl radical scavenging activity changes of ginseng and ginsenoside-Rb2 by heat processing", Biological and Pharmaceutical Bulletin, 303, pp.724~728 (2007)
31. Kang KS, "Increase in the free radical scavenging activity of ginseng by heatprocessing", Biological and Pharmaceutical Bulletin, 29, pp.750~754 (2006)
32. Kang KS, "Stereospecificity in hydroxyl radical scavenging activities of four ginsenosides produced by heat processing", Bioorganic & Medicinal Chemistry Letters, 16, pp.5028~5031 (2006)
33. Kang KS, "Effects of heat-processed ginseng and its active component ginsenoside 20(S)-Rg3 on the progression of renal damage and dysfunction in type 2 diabetic otsuka long-evans tokushima fatty rats", Biological and Pharmaceutical Bulletin, 33, pp.1077~1081 (2010)
34. Kang DI, "Evidence that the tertiary structure of 20(S)- ginsenoside Rg(3) with tight hydrophobic packing near the chiral center is important for Na+ channel regulation", Biochemical and Biophysical Research Communications, 333, pp.1194~1201 (2005)
35. Kang KS, "Increase in the free radical scavenging activities of American ginseng by heat processing and its safety evaluation", Journal of Ethnopharmacology, 113, pp.225~232 (2007)
36. Kang, KS, "ESR study on the structure and hydroxyl radicalscavenging activity relationships of ginsenosides isolated from Panax ginseng C. A. Meyer", Biological and Pharmaceutical Bulletin, 30, pp.917~921 (2007)
37. Karikura M, "Studies on absorption, distribution, excretion and metabolism of ginseng saponins. VII. Comparison of the decomposition modes of ginsenoside-Rb1 and-Rb2 in the digestive tract of rats", Chemical and Pharmaceutical Bulletin, 39, pp.2357~2361 (1991)
38. Kasai R, "Saponins of red ginseng", Chemical and Pharmaceutical Bulletin, 31, pp.2120~2125 (1983)
39. Keum YS, Park KK, Lee JM, Chun KS, Park JH, Lee SK, Kwon HJ and Surh YJ., "Antioxidant and anti-tumor promoting activities of the methanol extract of heat-processed ginseng", CANCER LETTERS, 150, pp.41~48 (2000), ELSEVIER IRELAND LTD
40. 백무열, "팽화에 의한 인삼 유효성분의 변화", Journal of the Korean Society for Applied Biological Chemistry, 51(3), pp.188~193 (2008), 한국응용생명화학회
41. Mi Hyun Kim, "Ginsenoside Changes in Red Ginseng Manufactured by Acid Impregnation Treatment", Journal of Ginseng Research, 34(2), pp.93~97 (2010), 고려인삼학회
42. Myung Kyum Kim, "Microbial Conversion of Major Ginsenoside Rb1 to Pharmaceutically Active Minor Ginsenoside Rd", The Journal of Microbiology, 43(5), pp.456~462 (2005), 한국미생물학회
43. 김낙두, "진세노사이드의 혈관확장작용과 분자기전", Journal of Ginseng Research, 32(2), pp.89~98 (2008), 고려인삼학회
44. Kim, ND, "Ginsenoside Rg3 inhibits phenylephrine-induced vascular contration through induction of nitric oxide synthase", British Journal of Pharmacology, 140, pp.661~670 (2003)
45. Kim SM, "Combination of ginsenoside Rg3 with docetaxel enhances the susceptibility", European Journal of Pharmacology, 631, pp.1~9 (2010)
46. Kim SW, "Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3)", Biochemical Pharmacology, 65, pp.75~82 (2003)
47. Kim WY, "Steaming of ginseng at high temperature enhances biological activity", Journal of Natural Products, 63, pp.1702~1704 (2000)
48. Kitagawa I, "Chemical studies of crude drug precession V. On the constituents of ginseng radix rubra(2) : Comparison of the constituents of white ginseng and red ginseng prepared from the same Panax ginseng root", Yakugaku Zasshi, 107, pp.495~505 (1987)
49. Kitagawa I, "Chemical studies of crude drug precession(I). On the constituents of ginseng radix rubra(1)", Yakugaku Zasshi, 103, pp.612~622 (1983)
50. Kitts DD, "Antioxidant properties of a north American ginseng extract", Molecular and Cellular Biochemistry, 203, pp.1~10 (2000)
51. 고성권, "Ginsenoside Composition Changes in Ginseng Extracts by Different Ascorbic Acid Treatments", Food Science and Biotechnology, 17(4), pp.883~887 (2008), 한국식품과학회
52. Sung Kwon Ko, "Change of Ginsenoside Composition in Ginseng Extract by Vinegar Process", Food Science and Biotechnology, 14(4), pp.509~513 (2005), 한국식품과학회
53. Ko SR, "Marked production of ginsenosides Rd, F2, Rg3, and compound", Chemical and Pharmaceutical Bulletin, 55, pp.1522~1527 (2007)
54. 공연희, "Ascorbic acid 및 citric acid 처리에 따른 홍삼추출물의 페놀성 성분 및 ginsenoside 함량 변화", Journal of Ginseng Research, 33(3), pp.194~198 (2009), 고려인삼학회
55. Kwok HH, "Stereoisomers ginsenosides-20(S)-Rg3 and -20(R)-Rg3 differentially induce angiogenesis through peroxisome proliferatoractivated receptor-gamma", Biochemical Pharmacology, 83, pp.893~902 (2012)
56. Hyog-Young Kwon, "Selective Toxicity of Ginsenoside Rg3 on Multidrug Resistant Cells by Membrane Fluidity Modulation", Archives of Pharmacal Research, 31(2), pp.171~177 (2008), 대한약학회
57. Seung-Yeol Nah, "Ginsentology Ⅱ: Chemical Structure-Biological Activity Relationship of Ginsenoside", Journal of Ginseng Research, 31(2), pp.69~73 (2007), 고려인삼학회
58. Lee BH, "Mutations of arginine 222 in pre-transmembrane domain I of mouse 5-HT(3A) receptor abolish 20(R)- but not 20(S)-ginsenoside Rg(3) inhibition of 5-HT-mediated ion currents", Biological and Pharmaceutical Bulletin, 30, pp.1721~1726 (2007)
59. Lee HU, "Hepatoprotective effect of 20(S)-ginsenosides Rg3 and its metabolite 20(S)-ginsenoside Rh2 on tert-butyl hydroperoxideinduced liver injury", Biological and Pharmaceutical Bulletin, 28, pp.1992~1994 (2005)
60. Lee J, "Studies on absorption, distribution and metabolism of ginseng in humans after oral administration", Journal of Ethnopharmacology, 122, pp.143~148 (2009)
61. 이지현, "흑삼의 제조 및 항암효과", 동의생리병리학회지, 20(4), pp.951~956 (2006), 대한동의병리학회
62. Lee KY, "Ginsenoside-Rg5 suppresses cyclin e-dependent protein kinase activity via up-regulating p21(Cip", WAF1)and down-regulating cyclinE in SK-HEP-1cells, 1997, pp.17, 1067~1072
63. Lee SM, Shon HJ, Choi CS, Hung TM, Min BS and Bae KH., "Ginsenosides from Heat Processed Ginseng", CHEMICAL & PHARMACEUTICAL BULLETIN, 57, pp.92~94 (2009), 일본약학회
64. Lee YJ, "The chemical and hydroxyl radical scavenging activity changes of ginsenoside-Rb1 by heat processing", Bioorganic & Medicinal Chemistry Letters, 18, pp.4515~4520 (2008)
65. Lee YJ, Kim HY, Kang KS, Lee JG, Yokozawa T and Park JH., "The chemical and hydroxyl radical scavenging activity changes of ginsenoside-Rb-1 by heat processing", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 18, pp.4515~4520 (2008), elsevier
66. Leung KW, "Pharmacology of ginsenosides: A literature review. Chinese Medicine. 11:5-20. Liang Y and Zhao S. (2008). Progress in understanding of ginsenoside biosynthesis", Plant Biology, 10, pp.415~421 (2008)
67. Liu CX, "Recent advances on ginseng research in China", Journal of Ethnopharmacology, 36, pp.27~38 (1992)
68. Liu TG, "Inhibitory effect of ginsenoside Rg3 combined with gemcitabine on angiogenesis and growth of lung cancer in mice", BMC Cancer, 9, pp.250~ (2009)
69. Wei Li, "Anti-androgen-independent Prostate Cancer Effects of Ginsenoside Metabolites In Vitro: Mechanism and Possible Structure-Activity Relationship Investigation", Archives of Pharmacal Research, 32(1), pp.49~57 (2009), 대한약학회
70. 李翔国, "홍삼 물 추출액의 사포닌 함량 및 맛의 증진을 위한 추출 조건", 한국작물학회지, 54(3), pp.287~293 (2009), 한국작물학회
71. Li X, "Pharmacokinetic and absolute bioavailability study of total panax notoginsenoside, a typical multiple constituent traditional chinese medicine(TCM)in rats", Biological and Pharmaceutical Bulletin, 30, pp.847~851 (2007)
72. Matsuda H, "Chemical changes of ginsenoside- Rbl in stomach and improving effects of product, 20(S)-ginsenoside-Rg3 on a peripheral circulation disorder", The Ginseng Review, pp.12~15 (2000)
73. Matsuura H, "Further studies on the dammaranesaponins of ginseng roots", Chemical and Pharmaceutical Bulletin, 32, pp.1188~1192 (1984)
74. Mochizuki M, "Inhibitory effect of tumor metastasis in mice by saponins, ginsenoside Rb2, 20(R)-and 20(S)-ginsenoside Rg3, of red ginseng", Chemical and Pharmaceutical Bulletin, 18, pp.1197~1202 (1995)
75. Nag SA, "Ginsenosides as anticancer agents : In vitro and in vivo activities, structure-activity relationships, and molecular mechanisms of action", Frontiers in Pharmacology, 3, pp.25~ (2012)
76. 남기열, "고려인삼의 주요 효능과 그 임상적 응용", Journal of Ginseng Research, 26(3), pp.111~131 (2002), 고려인삼학회
77. 남기열, "흑삼 제조과정 중 증포 횟수에 따른 색상 및 진세노사이드 함량 변화", 한국약용작물학회지, 20(1), pp.27~35 (2012), 한국약용작물학회
78. 남기열, "홍삼과 백삼의 비교 고찰", Journal of Ginseng Research, 29(1), pp.1~18 (2005), 고려인삼학회
79. Namba T, "Saponins of plants of Panax species collected in central Nepal and their chemotaxonomical significance", Chemical and Pharmaceutical Bulletin, 34, pp.730~738 (1986)
80. Ni JS, "Effect of 20(S)-ginsenoside Rg3 combined with cytotoxic agents on sarcoma 180 of mice", Journal of Jilin University of Medicine Edition, 31, pp.705~708 (2005)
81. Noh KH, "Production of the rare ginsenosides compound K, compound Y, and compound Mc by a thermostable betaglycosidase from Sulfolobus acidocaldarius", Biological and Pharmaceutical Bulletin, 32, pp.1830~1835 (2009)
82. Noh KH, "Ginsenoside compound K production from ginseng root extract by a thermostable betaglycosidase from Sulfolobus solfataricus", Biotechnology and Biochemistry, 73, pp.316~321 (2009)
83. Park CS, "Biotransformation of ginsenosides by hydrolyzing the sugar moieties of ginsenosides using microbial glycosidases", Applied Microbiology and Biotechnology, 87, pp.9~19 (2010)
84. Park EK, "Antiallergic activity of ginsenoside Rh2", Biological and Pharmaceutical Bulletin, 26, pp.1581~1584 (2003)
85. Popovich DG, "Generation of ginsenosides Rg3 and Rh2 from north American ginseng", Phytochemistry, 65, pp.337~344 (2004)
86. Park IH, "Cytotoxic dammarane glycosides from processed ginseng", Chemical and Pharmaceutical Bulletin, 50, pp.538~540 (2002)
87. Park JD., "Recent studies on the chemical constituents of Korean ginseng(Panax ginseng C. A. Meyer)", Journal of Ginseng Research, 20, pp.389~415 (1996)
88. Park MW, "20(S)-Ginsenoside Rg3 enhances glucose-stimulated insulin secretion and activates AMPK", Biological and Pharmaceutical Bulletin, 31, pp.748~751 (2008)
89. Popovich DG, "Structure-function relationship exists for ginsenosides in reducing cell proliferation and inducing apoptosis in the human leukemia(THP-1)cell line", Archives of Biochemistry and Biophysics, 406, pp.1~88 (2002)
90. Qi LW, "Ginsenosides from American ginseng : Chemical and pharmacological diversity", Phytochemistry, 72, pp.689~699 (2011)
91. Qi LW, "American ginseng: Potential structure-function relationship in cancer chemoprevention", Biochemical Pharmacology, 80, pp.947~954 (2010)
92. Qi LW, "Isolation and analysis of ginseng : advances and challenges", Natural Product Reports, 28, pp.467~495 (2011)
93. Qian TX, "In vivo rat metabolism and pharmacokinetic studies of ginsenoside Rg3", Journal of Chromatography B Analytical Technologies in the Biomedical and Life Sciences, 25, pp.223~232 (2005)
94. Quan LH, "Enzymatic biotransformation of ginsenoside Rb1 to 20(S)-Rg3by recombinant β-glucosidase from Microbacterium esteraromaticum", Applied Microbiology and Biotechnology, 94, pp.377~384 (2012)
95. Sanada S, "Studies on the saponin of ginseng. I. Structures of ginsenoside-Ro, -Rb1, -Rc, and-Rd", Chemical and Pharmaceutical Bulletin, 22, pp.421~428 (1974)
96. hibata S, "Chemical studies on the oriental plant drugs. XVII. The prosapogenin of the ginseng saponins(ginsenosides-Rb1, -Rb2, and -Rc)", Chemical and Pharmaceutical Bulletin, 14, pp.1157~1161 (1966)
97. Shibata S, "Protopanaxadiol : a genuin sapogenin of ginseng saponins", Chemical and Pharmaceutical Bulletin, 14, pp.595~600 (1966)
98. Shibata S, "Studies on saponins and sapogenins of ginseng : The structure of panaxatriol", Tetrahedron Letters, 21, pp.207~213 (1965)
99. Shibata S., "Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds", Journal of Korean Medical Science, 16, pp.28~37 (2001)
100. Shibata S., "On genuine sapogenin of ginseng", Tetrahedron Letters, 19, pp.795~800 (1963)
101. Shin YW, "Metabolism of ginsenoside Rg5,a main constituent isolated from red ginseng, by human intestinal microflora and their antiallergic effect", Journal of Microbiology and Biotechnology, 169, pp.1791~1798 (2006)
102. Shinkai K, "Inhibition of in vitro tumor cell invasion by ginsenoside Rg3", Japanese Journal of Cancer Research, 87, pp.357~362 (1996)
103. Shoji J., "Recent advances in ginseng studies", pp.11~31 (1990), Hirokawa Publishing
104. Su JH, "Enzymatic transformation of ginsenoside Rg3 to Rh2 using newly isolated Fusarium proliferatum ECU2042", Journal of Molecular Catalysis B : Enzymatic, 38, pp.113~118 (2006)
105. Bai-Shen Sun, "Determination of 11 Ginsenosides in Black Ginseng Developed from Panax ginseng by High Performance Liquid Chromatography", Food Science and Biotechnology, 18(2), pp.561~564 (2009), 한국식품과학회
106. Sun CP, "Conversion of protopanaxadiol type saponins to ginsenoside Rg3 by lemon", Natural Product Communications, 7, pp.1155~1156 (2012)
107. Sun S, "Red notoginseng : higher ginsenoside content and stronger anticancer potential than Asian and American ginseng", Food Chemistry, 125, pp.1299~1305 (2011)
108. Tansakul P, "Dammarenediol-II synthase, the first dedicated enzyme for ginsenoside biosynthesis, in Panax ginseng", FEBS Letters, 580, pp.5143~5149 (2006)
109. Tawab MA, "Degradation of ginsenosides in humans after oral administration", Drug Metabolism and Disposition, 31, pp.1065~1071 (2003)
110. Tian JW, "Neuroprotective effect of 20(S)-ginsenoside Rg3 on cerebral ischemia in rats", Neuroscience Letters, 374, pp.92~97 (2005)
111. Toh DF, "Anti-proliferative effects of raw and steamed extracts of Panax notoginseng and its ginsenoside constituents on human liver cancer cells", Chinese Medicine, 24, pp.6~148 (2011)
112. Wakabayashi C, "An intestinal bacterial metabolite of ginseng protopanaxadiol saponins has the ability to induce apoptosis in tumor cells", Biochemical and Biophysical Research Communications, 246, pp.725~730 (1998)
113. Wang CZ, "Red American ginseng : Ginsenoside constituents and antiproliferative activities of heat-processed Panax quinquefolius roots", Planta Medica, 73, pp.669~674 (2007)
114. Wang CZ, "Chemopreventive effects of heat-processed Panax quinquefolius root on human breast cancer cells", Anticancer Research, 28, pp.2545~2552 (2008)
115. Wang CZ, "The mitochondrial pathway is involved in American ginseng-induced apoptosis of SW-480 colon cancer cells", Oncology Reports, 21, pp.577~584 (2009)
116. Wang P, "Semi-synthesis and anti-tumor evaluation of novel 25-hydroxyprotopanaxadiol derivatives", European Journal of Medicinal Chemistry, 55, pp.137~145 (2012)
117. Wang W, "Experimental therapy of prostate cancer with novel natural product anti-cancer ginsenosides", The Prostate, 68, pp.809~819 (2008)
118. Wang W, "Anti-lung cancer effects of novel ginsenoside 25- OCH(3)-PPD", Lung Cancer, 65, pp.306~331 (2009)
119. Wang W, "20(S)-25- methoxyl-dammarane-3beta,12beta, 20- triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action", British Journal of Cancer, 98, pp.792~802 (2008)
120. Wang W, "In vitro anti-cancer activity and structure-activity relationships of natural products isolated from fruits of Panax ginseng", Cancer Chemotherapy and Pharmacology, 59, pp.589~601 (2007)
121. Wei X, "Stereospecificity of ginsenoside Rg3 in promotion of the immune response to ovalbumin in mice", International Immunology, 24, pp.465~471 (2012)
122. Wei X, "Stereospecific antioxidant effects of ginsenoside Rg3 on oxidative stress induced by cyclophosphamide in mice", Fitoterapia, 83, pp.636~642 (2012)
123. Xie HT, "High performance liquid chromatographic-mass spectrometric determination of ginsenoside Rg3 and its metabolite in rat plama using solidphase extration for pharmacokinetic studies", Journal ofChromatography B Analytical Technologies in the Biomedical and Life Sciences, 818, pp.167~173 (2005)
124. Xu TM, "Inhibitory effect of ginsenoside Rg3 combined with cyclophosphamide on growth and angiogenesis of ovarian cancer", Chinese Medical Journal, 120, pp.584~588 (2007)
125. Yan Q, "Purification method improvement and characterization of a novel ginsenosidehydrolyzing beta-glucosidase from Paecilomyces bainier sp. 229", bioscience Biotechnology and Biochemistry, 72, pp.352~359 (2008)
126. Yang LQ, "Enhanced oral bioavailability and anti-tumour effect of paclitaxel by 20(s)-ginsenoside Rg3 in vivo", Biopharmaceutics and Drug Disposition, 33, pp.425~436 (2012)
127. 양승준, "고온고압처리에 의한 인삼의 성분 변화", 한국식품과학회지, 38(4), pp.521~525 (2006), 한국식품과학회
128. Yokozawa T, "Therapeutic potential of heat-processed Panax ginseng with respect to oxidative tissue damage", Drug Discoveries & Therapeutics, 1, pp.30~44 (2007)
129. Yoo MH, "Production of aglycon protopanaxadiol via compound K by a thermostable β-glycosidase from Pyrococcus furiosus", Applied Microbiology and Biotechnology, 89, pp.1019~1028 (2011)
130. Yu H, "Purification and characterization of new special ginsenosidase hydrolyzing multiglycisides of protopanaxadiol ginsenosides, ginsenosidase type I", Chemical and Pharmaceutical Bulletin, 55, pp.231~233 (2007)
131. Yu Y, "Antiestrogenic effect of 20S- protopanaxadiol and its synergy with tamoxifen on breast cancer cells", Cancer, 109, pp.2374~2382 (2007)
132. Yue CJ, "Purification and characterization of UDPG: Ginsenoside Rd glucosyltransferase from suspended cells of Panax notoginseng", Process Biochemistry, 40, pp.3742~3748 (2005)
133. Yue CJ, "Protopanaxadiol 6-hydroxylase and its role in regulating the ginsenoside heterogeneity in Panax notoginseng cells", Biotechnology and Bioengineering, 100, pp.933~940 (2008)
134. Yue PY, "Pharmacogenomics and the Yin", Yang actions of ginseng : Anti-tumor, angiomodulating and steroid-like activities of ginsenosides, 2007, pp.15, 2~6
135. Yue PY, "The angiosuppressive effects of 20(R)-ginsenoside Rg(3)", Biochemical Pharmacology, 72, pp.437~445 (2006)
136. Yun TK, "Anticarcinogenic effect of Panax ginseng C. A. Meyer and identification", Journal of Korean Medical Science, 16, pp.6~186 (2001)
137. Zhou W, "Biotransformation of Panax notoginseng saponins into ginsenoside compound K production by Paecilomyces bainier sp. 229", Journal of Applied Microbiology, 104, pp.699~706 (2008)

관련 논문AI추천